23Andme Holding Co. Grants New FDA Clearance to Report Addit

23andMe Holding Co. announced the Company has received a U.S. Food and Drug Administration 510 clearance to expand its existing BRCA1/BRCA2 Genetic Health Risk Report. The clearance allows 23andMe...

Related Keywords

United States , American , , Genetic Health Risk , Sme Health , Drug Administration , Ancestry Service , Variants Genetic Health Risk , Genome Service , Me Holding Co , Selected Variants , Ashkenazi Jewish , African American , Predetermined Change Control Plan , Submission Recommendations , Machine Learning Enabled Device Software , Ashkenazi European , East Asian , Genetic Health Risk Report , Personal Genome , Markets ,